HappeningToo topic

Pancrelipase reports

Browse community reports connected to Pancrelipase. These reports can show that other people are describing similar experiences, but they do not prove that Pancrelipase caused a symptom or reaction.

⚕️ Medicine safety note

Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.

34 problems

Abdominal Discomfort while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and abdominal discomfort appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Distension while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and abdominal distension appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and abdominal pain upper appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and abdominal pain appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Acid reflux while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and acid reflux appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Alopecia while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and alopecia appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Anxiety while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and anxiety appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and back pain appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Chest Discomfort while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and chest discomfort appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and constipation appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and cough appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and decreased appetite appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and dehydration appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and diarrhea appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and dizziness appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dyspepsia while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and dyspepsia appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and fatigue appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and feeling abnormal appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Flatulence while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and flatulence appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and headache appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and hypotension appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and insomnia appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and itching appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and malaise appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and muscle spasms appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and nausea appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and pain appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and peripheral swelling appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and rash appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and shortness of breath appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and vomiting appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and weakness appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and weight decreased appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Pancrelipase

FDA FAERS contains adverse-event reports in which Pancrelipase and weight increased appear together. This does not establish that Pancrelipase caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →